Newmed Energ Pu (NWMD) AI Stock Analysis

• Market Cap: ₪24.36B
• Dividend Yield: 3.95%
• Average Volume (3M): 1.02M
• Price to Earnings (P/E): 15.4
• Beta (1Y): 1.13
• Revenue Growth: -15.01%
• EPS Growth: -16.12%
• Country: IL
• Employees: 23
• Sector: Energy
• Sector Strength: 52
• Industry: Oil & Gas Exploration & Production
• EPS (TTM): 36.80
• Shares Outstanding: 1,173,814,700
• 10 Day Avg. Volume: 836,117
• 30 Day Avg. Volume: 1,024,307
• PEG Ratio: 0.32
• Price to Book (P/B): 2.01
• Price to Sales (P/S): 3.16
• P/FCF Ratio: 7.75
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 71 Outperform
• Price Target: 2,293.00 ▲(19.74% Upside)

Newmed Energ Pu's strong valuation and solid financial performance are the main drivers of its score. While technical indicators are neutral, the company's reasonable P/E ratio and attractive dividend yield enhance its investment appeal. Monitoring revenue and cash flow trends is advised.

Positive Factors

Diversified revenue streams & government support

Multiple revenue streams—equipment sales, installations, maintenance and consultancy—reduce reliance on any single income source. Coupled with government incentives and partnerships, this creates durable demand tailwinds and more predictable project pipelines over the next several quarters.

High margins and strong ROE

Sustained high EBIT/EBITDA and net margins plus strong ROE indicate efficient operations and pricing power. These fundamentals support reinvestment, resilience to input-cost shocks, and the ability to generate shareholder returns even if top-line growth temporarily softens.

Healthy operating cash conversion

A healthy operating cash flow to net income ratio shows effective cash conversion of profits, supporting capex, maintenance and working capital without undue reliance on external financing. This provides financial flexibility for project execution and steady operations.

Negative Factors

Declining revenue and free cash flow growth

A noticeable decline in revenue and free cash flow growth in the trailing period undermines the firm’s ability to fund growth and service obligations organically. If persistent, this pressures reinvestment, limits expansion capacity and may force higher external financing.

Leverage still relatively high

Although leverage has improved, a still-elevated debt-to-equity ratio reduces financial flexibility. In a capital-intensive renewables environment, high leverage raises refinancing and interest-rate sensitivity, constraining the firm’s ability to invest or absorb revenue shocks.

Small operating scale

A very small employee base limits internal capacity to manage large or multiple simultaneous projects, scale sales and service networks, and may increase reliance on external partners. This can slow growth execution and raise operational risk as project scope expands.

Newmed Energ Pu Business Overview & Revenue Model

Company Description

NewMed Energy - Limited Partnership engages in the exploration, development, production, and sale of petroleum, natural gas, and condensate in Israel and Cyprus. The company holds interests in the Leviathan project, which covers an area of 500 square kilometer (km2) located to the west of the shores of Haifa; the Block 12 that covers an area of approximately 386 km2 located in Cyprus; and the Yam Tethys project, which covers an area of approximately 500 km2 located to the west of the shores of Ashkelon. It also holds interests in the Boujdour Atlantique exploration license that covers an area of approximately 33,812 km2 located in the south of the Moroccan exclusive economic zone; and the Tanin and Karish leases covering an area of approximately 500km2 located to the west of the shores of Nahariya. The company serves independent power producers, marketing companies, and industrial customers, as well as exports natural gas to Jordan and in Egypt. NewMed Energy Management Ltd. serves as the general partner of the company. The company was formerly known as Delek Drilling - Limited Partnership and changed its name to NewMed Energy - Limited Partnership in February 2022. NewMed Energy - Limited Partnership was incorporated in 1993 and is based in Herzliya, Israel. NewMed Energy - Limited Partnership is a subsidiary of Delek Energy Systems Ltd.

How the Company Makes Money

Newmed Energ Pu generates revenue through multiple streams, including the sale and installation of renewable energy systems, maintenance services for existing installations, and consultancy services in energy efficiency. Additionally, the company benefits from government incentives and subsidies aimed at promoting renewable energy adoption. Significant partnerships with technology providers and local governments enhance NWMD's market reach and contribute to its earnings by facilitating large-scale projects and ensuring compliance with regulatory standards.

Newmed Energ Pu Financial Statement Overview

Summary

Newmed Energ Pu shows strong profitability with high margins and return on equity. However, recent declines in revenue and free cash flow growth are concerns that need monitoring.

Income Statement

Newmed Energ Pu has demonstrated strong profitability with a high EBIT and EBITDA margin, indicating efficient operations. However, the recent TTM data shows a decline in revenue growth, which could be a concern if it continues. The net profit margin remains robust, suggesting effective cost management.

Balance Sheet

The company has improved its debt-to-equity ratio over the years, indicating better leverage management. However, the ratio is still relatively high, which could pose risks in volatile market conditions. The return on equity is strong, reflecting good profitability relative to shareholder equity.

Cash Flow

The cash flow statement shows a decline in free cash flow growth in the TTM period, which could impact future investments. The operating cash flow to net income ratio is healthy, indicating good cash generation relative to earnings. However, the decrease in free cash flow growth is a potential concern.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	1.02B	1.14B	934.60M	1.14B	882.50M	587.10M
Gross Profit	628.70M	718.10M	780.70M	701.70M	518.11M	535.48M
EBITDA	747.20M	874.80M	782.70M	872.10M	657.20M	524.20M
Net Income	445.60M	524.60M	433.60M	469.70M	404.90M	365.30M
Balance Sheet
Total Assets	3.95B	3.99B	3.85B	3.94B	3.85B	4.58B
Cash, Cash Equivalents and Short-Term Investments	240.30M	384.50M	186.70M	418.30M	340.85M	239.35M
Total Debt	1.42B	1.63B	1.82B	2.16B	2.22B	3.25B
Total Liabilities	2.02B	2.21B	2.33B	2.65B	2.91B	3.59B
Stockholders Equity	1.93B	1.79B	1.51B	1.29B	938.54M	997.70M
Cash Flow
Free Cash Flow	330.50M	463.30M	423.10M	405.80M	423.25M	163.59M
Operating Cash Flow	514.10M	577.50M	559.50M	504.70M	453.64M	328.68M
Investing Cash Flow	47.30M	-114.20M	36.10M	-273.50M	982.04M	-241.82M
Financing Cash Flow	-524.40M	-441.20M	-588.90M	-429.10M	-1.29B	-187.92M

Newmed Energ Pu Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1915.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:NWMD, the sentiment is Positive. The current price of 1915 is below the 20-day moving average (MA) of 1930.60, above the 50-day MA of 1815.12, and above the 200-day MA of 1604.22, indicating a bullish trend. The MACD of 55.28 indicates Negative momentum. The RSI at 58.58 is Neutral, neither overbought nor oversold. The STOCH value of 83.55 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IL:NWMD.

Newmed Energ Pu Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
RATI	73 Outperform	₪5.59B	12.24	27.38%	8.82%	-15.49%	-8.29%
NWMD	71 Outperform	₪24.36B	15.36	24.33%	3.95%	-15.01%	-16.12%
TMRP	65 Neutral	₪2.78B	19.35	―	7.38%	5.30%	-23.48%
Sector *	65 Neutral	$15.17B	7.61	4.09%	5.20%	3.87%	-62.32%
DLEKG	58 Neutral	₪16.73B	4.79	4.49%	6.64%	17.71%	211.99%
NVPT	44 Neutral	₪13.92B	-67.08	―	―	69.61%	-282.20%